title: Pain management with intravenous ketorolac.
abstract: OBJECTIVE
  To report a case in which intravenous ketorolac was used successfully on a chronic basis to treat cancer pain.
  
  
  METHODS
  Clinical and compatibility studies obtained through a computer literature search.
  
  
  METHODS
  We identified five reports that specifically addressed intravenous dosing of ketorolac.
  
  
  RESULTS
  A 41-year-old man received pain relief from intravenous injections of ketorolac for 11 months. As far as we know, there are no other reports in the literature in which intravenous ketorolac has been used on a chronic basis.
  
  
  CONCLUSIONS
  Experience at our institution indicates that intravenous ketorolac is a useful, well-tolerated nonsteroidal antiinflammatory drug that should be investigated further for use in selected pain models.
authors.affiliation: Division of Pharmacy, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: L J
authors.initials: LJ
authors.lastname: Miller
authors.forename: M A
authors.initials: MA
authors.lastname: Kramer
mesh_terms: D000230:Adenocarcinoma / Q000503:physiopathology; D000328:Adult; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D001650:Bile Duct Neoplasms / Q000503:physiopathology; D002908:Chronic Disease; D006801:Humans; D007275:Injections, Intravenous; D020910:Ketorolac; D008297:Male; D010146:Pain / Q000188:drug therapy*; D013997:Time Factors; D014046:Tolmetin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D014046:Tolmetin; D020910:Ketorolac